---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-25-000034"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:07:25.939724+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q3 revenue down 8.8% YoY; adjusted EPS improves to $2.03

## Summary
- Q3 revenue $537M vs $589M YoY; GAAP net loss narrowed to $3.4M from $33M.
- Adjusted diluted EPS $2.03 vs $1.59 YoY; adjusted EBITDA $105.9M vs $94.8M.
- GAAP gross margin improved to 37% from 35% YoY.
- Company updated fiscal year 2025 guidance; details in press release.

## SEC filing metadata
- accession: 0000883984-25-000034
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398425000034/0000883984-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398425000034/icui-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-25-000034
- JSON: https://secwatch.observer/filing/0000883984-25-000034.json
- Plain text: https://secwatch.observer/filing/0000883984-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.